maternity - Nursing Case Study
Pathophysiology
• Primary mechanism: Hemodynamic changes - Pregnancy induces a hyperdynamic circulatory state, increasing blood volume by 30-50% to meet fetal and placental needs, which can stress the cardiovascular system and exacerbate conditions like hypertension.
• Secondary mechanism: Hormonal adaptations - Elevated levels of progesterone and estrogen alter vascular resistance and renal function, impacting fluid balance and potentially leading to conditions such as gestational diabetes and preeclampsia.
• Key complication: Preeclampsia - Characterized by hypertension and proteinuria after 20 weeks of gestation, it results from abnormal placental development and can lead to significant maternal and fetal morbidity if not managed appropriately.
Patient Profile
Demographics:
32-year-old female, school teacher
History:
• Key past medical history: Gestational diabetes in previous pregnancy, mild hypertension
• Current medications: Prenatal vitamins, Labetalol 100 mg twice daily
• Allergies: Penicillin
Current Presentation:
• Chief complaint: Persistent headache and swelling in hands and feet
• Key symptoms: Elevated blood pressure, fatigue, occasional visual disturbances
• Vital signs: Blood pressure 150/95 mmHg, heart rate 92 bpm, respiratory rate 18 breaths per minute, temperature 98.6°F
Section 1
New Diagnostic Results:
As the healthcare team continues to monitor the patient's condition, further assessments are conducted to evaluate the possibility of preeclampsia. A 24-hour urine collection is ordered to assess proteinuria, and the results reveal a protein level of 350 mg per 24 hours, confirming significant proteinuria indicative of preeclampsia. Additionally, laboratory tests show elevated liver enzymes, with AST at 55 U/L and ALT at 60 U/L, suggesting potential liver involvement. Platelet count remains within normal range, but close monitoring is advised due to the risk of progression to HELLP syndrome, a severe form of preeclampsia involving hemolysis, elevated liver enzymes, and low platelets.
The patient's blood pressure remains elevated despite ongoing antihypertensive therapy, with readings consistently around 150/95 mmHg. A non-stress test (NST) is performed to assess fetal well-being, and it reveals a reactive pattern, indicating that the fetus is currently coping well. However, the presence of visual disturbances and persistent headache are concerning signs that necessitate further evaluation and close surveillance. The healthcare team discusses the potential need for hospitalization to ensure maternal and fetal safety, particularly if symptoms progress or additional complications arise.
These findings prompt the healthcare team to consider adjustments in the patient's management plan. The importance of frequent monitoring, both clinically and through laboratory evaluations, is emphasized to detect any worsening of the condition. The patient and her family are counseled on the signs and symptoms that should prompt immediate medical attention, including severe headache, vision changes, or sudden worsening of edema. This collaborative approach aims to optimize outcomes for both the mother and the fetus, balancing the risks of early delivery against the potential complications of untreated preeclampsia.
Section 2
Change in Patient Status:
As the days progress, the patient begins to exhibit subtle yet concerning changes in her clinical status. Her blood pressure remains persistently elevated, now averaging around 155/100 mmHg despite adjustments in her antihypertensive regimen. The healthcare team becomes increasingly vigilant, aware of the delicate balance between controlling maternal hypertension and ensuring adequate placental perfusion to support fetal growth and well-being. The patient's persistent headache intensifies, and she reports experiencing new onset of epigastric pain, raising alarm for potential worsening of her condition.
A repeat set of laboratory tests is ordered to assess for any further progression towards HELLP syndrome. The results reveal a slight decrease in platelet count, now at 140,000/µL, which, although still within normal limits, indicates a downward trend that warrants close monitoring. Liver enzyme levels remain elevated but stable, with AST at 60 U/L and ALT at 65 U/L. The healthcare team discusses these findings, recognizing the importance of timely intervention to prevent further deterioration. Given the new symptoms and lab trends, the decision is made to admit the patient to the hospital for more intensive monitoring and management.
Upon admission, the patient's care plan is adjusted to include continuous fetal monitoring to assess for any signs of fetal distress. The obstetric team initiates a magnesium sulfate infusion as a prophylactic measure against seizures, given the escalating risk of eclampsia. The patient and her family are provided with comprehensive information about the rationale for these interventions and the potential need for expedited delivery should maternal or fetal conditions worsen. This proactive approach underscores the commitment to safeguarding the health of both mother and child, emphasizing the need for ongoing assessment and readiness to adapt the care plan as necessary.
Section 3
As the patient settles into the hospital setting, the initial assessment upon admission reveals a blood pressure of 160/105 mmHg, despite the ongoing antihypertensive therapy. Her headache persists, described as a throbbing sensation, and she rates it at a 7 out of 10 on the pain scale. The epigastric pain is now more pronounced, with the patient pointing to the upper right quadrant as the area of discomfort. On physical examination, mild facial edema is noted, and deep tendon reflexes are brisk, highlighting a potential progression towards a more severe hypertensive disorder.
Continuous fetal monitoring shows reactive patterns with occasional variable decelerations, raising concern for potential fetal distress. The healthcare team discusses the need for close surveillance, acknowledging the delicate balance of managing the patient’s hypertension while ensuring adequate placental function. A biophysical profile and Doppler study are ordered to assess fetal well-being more comprehensively and to evaluate placental blood flow.
In response to the interventions, the patient is started on a magnesium sulfate infusion, with serum magnesium levels closely monitored to maintain therapeutic range and prevent toxicity. Labs are repeated to track any progression of HELLP syndrome, with a focus on platelet count and liver enzymes. The nursing team remains vigilant for any signs of magnesium toxicity, such as loss of patellar reflexes or respiratory depression, while also preparing for the possibility of expedited delivery. The patient's clinical trajectory necessitates a dynamic and responsive care plan, as the team considers the potential for emergent interventions to safeguard both maternal and fetal outcomes.
Section 4
New Diagnostic Results:
Following the initial interventions, the biophysical profile reveals a score of 6/10, indicating moderate fetal compromise. The Doppler study shows increased resistance in the uterine arteries, suggestive of poor placental perfusion. These findings correlate with the occasional variable decelerations noted on continuous fetal monitoring, raising concerns about the potential for intrauterine growth restriction and further fetal distress. The patient's liver function tests reveal elevated liver enzymes, with aspartate aminotransferase (AST) at 95 U/L and alanine aminotransferase (ALT) at 110 U/L, both above normal limits. Her platelet count has decreased to 115,000/mm³, pointing towards a progression in the spectrum of HELLP syndrome.
In light of these diagnostic results, the healthcare team reassesses the patient’s management plan. The worsening laboratory values and fetal indicators necessitate a multidisciplinary discussion about the timing of delivery. The obstetrician, in consultation with the neonatologist, emphasizes the importance of weighing the risks of continued expectant management against the potential benefits of preemptive delivery to prevent further maternal and fetal compromise. The team re-evaluates the current antihypertensive regimen, considering potential adjustments to optimize blood pressure control while minimizing adverse effects on uteroplacental blood flow.
The nursing team plays a critical role in ongoing surveillance, closely monitoring the patient for signs of worsening hypertension or magnesium toxicity. Vital signs are checked every 15 minutes, with a particular focus on blood pressure stability and respiratory rate. Despite the challenges, the patient remains alert and oriented, though her discomfort from the headache and epigastric pain persists. The healthcare team remains on high alert, prepared for potential emergent interventions, including the administration of additional medications or the initiation of an expedited delivery protocol, should the clinical situation demand it. This proactive approach aims to ensure the best possible outcomes for both the mother and her baby.
Section 5
Change in Patient Status:
As the hours progress, the patient's clinical status undergoes a concerning shift. Her blood pressure readings have gradually increased, now reaching 165/110 mmHg despite the current antihypertensive regimen. Concurrently, she reports a worsening headache, described as throbbing and unrelieved by analgesics. Her deep tendon reflexes, initially brisk, have become markedly hyperactive, accompanied by clonus. These findings raise the suspicion of escalating preeclampsia, necessitating immediate reassessment of her management plan.
Simultaneously, fetal monitoring reveals an increase in the frequency and depth of variable decelerations, with occasional late decelerations suggesting compromised fetal oxygenation. The decision is made to administer a bolus of magnesium sulfate to prevent eclamptic seizures, calling for vigilant monitoring for signs of magnesium toxicity, particularly focusing on respiratory rate and urinary output. The nursing team diligently records these parameters, noting a concerning trend of decreased urinary output at 20 mL/hour, which warrants immediate attention to avoid further complications.
In light of these developments, an urgent multidisciplinary meeting is convened to discuss the potential need for expedited delivery. The obstetrician outlines the risks of continuing conservative management against the backdrop of a potentially deteriorating maternal and fetal condition. The neonatologist provides an updated assessment of the neonatal team's preparedness for preterm delivery, emphasizing the protocols in place for potential neonatal resuscitation and care in the NICU. The team collectively leans towards a decision to proceed with delivery, prioritizing the safety and well-being of both the mother and her baby, while ensuring that all necessary support systems are in place for this critical transition.